CoChat

Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Women with the polycystic ovary syndrome have insulin resistance and hyperinsulinemia, possibly because of a deficiency of a D-chiro-inositol-containing phosphoglycan that mediates the action of insulin. We hypothesized that the administration of D-chiro-inositol would replenish stores of the mediator and improve insulin sensitivity. METHODS: We measured steroids in serum and performed oral glucose-tolerance tests before and after the oral administration of 1200 mg of D-chiro-inositol or placebo once daily for six to eight weeks in 44 obese women with the polycystic ovary syndrome. The serum progesterone concentration was measured weekly to monitor for ovulation. RESULTS: In the 22 women given D-chiro-inositol, the mean (+/-SD) area under the plasma insulin curve after the oral administration of glucose decreased from 13,417+/-11,572 to 5158+/-6714 microU per milliliter per minute (81+/-69 to 31+/-40 nmol per liter per minute) (P=0.007; P=0.07 for the comparison of this change with the change in the placebo group); glucose tolerance did not change significantly. The serum free testosterone concentration in these 22 women decreased from 1.1+/-0.8 to 0.5+/-0.5 ng per deciliter (38+/-7 to 17+/-3 pmol per liter) (P=0.006 for the comparison with the change in the placebo group). The women's diastolic and systolic blood pressure decreased by 4 mm Hg (P<0.001 and P=0.05, respectively, for the comparisons with the changes in the placebo group), and their plasma triglyceride concentrations decreased from 184+/-88 to 110+/-61 mg per deciliter (2.1+/-0.2 to 1.2+/-0.1 mmol per liter) (P=0.002 for the comparison with the change in the placebo group). None of these variables changed appreciably in the placebo group. Nineteen of the 22 women who received D-chiro-inositol ovulated, as compared with 6 of the 22 women in the placebo group (P<0.001). CONCLUSIONS: D-Chiro-inositol increases the action of insulin in patients with the polycystic ovary syndrome, thereby improving ovulatory function and decreasing serum androgen concentrations, blood pressure, and plasma triglyceride concentrations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199904293401703

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 4

  1. Larner J, 1994, Endocr J, 2, 167
  2. Craig JW, Larner J, Asplin CM. Chiro-inositol deficiency and insulin resistance. In: Draznin B, LeRoith D, eds. Molecular biology of diabetes. Part 2. Totowa, N.J.: Humana Press, 1994:343-62.
  3. 10.1210/en.132.2.646 · doi:10.1210/en.132.2.646 · Paper page
  4. 10.1210/jc.82.7.2108 · doi:10.1210/jc.82.7.2108 · Paper page

Cited by

See all 518

Metadata

Authors
Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., & Allan, G.
Affiliations
  • Virginia Commonwealth University (US)
  • Hospital Clínico Universitario de Caracas (VE)
Venue
New England Journal of Medicine
Published
1999-04-29
Volume
340
Issue
17
Pages
1314-1320
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2095365589
Cited by
518
References
45
Citations by year
2026: 12 · 2025: 18 · 2024: 9 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 25 · 2019: 14 · 2018: 19 · 2017: 20 · 2016: 34 · 2015: 24 · 2014: 16 · 2013: 21 · 2012: 19
FWCI
25.70
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion)
Funders
  • National Institutes of Health (1r43hd035772-01)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R43HD35772)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords
polycystic ovary syndrome, insulin resistance, hyperinsulinemia, insulin sensitivity, insulin receptor substrate, insulin receptor substrate 2, IRS-1, insulin signaling
MeSH terms
Adolescent, Adult, Androgens, Blood Glucose, Female, Humans, Inositol, Insulin, Luteinizing Hormone, Lipids, Ovulation, Polycystic Ovary Syndrome, 17-alpha-Hydroxyprogesterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.1056/nejm199904293401703
The paper
Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., & Allan, G. (1999). Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome. New England Journal of Medicine. https://doi.org/10.1056/nejm199904293401703

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.